首页 | 本学科首页   官方微博 | 高级检索  
检索        


Presence of functional cannabinoid receptors in human endocrine pancreas
Authors:F J Bermúdez-Silva  J Suárez  E Baixeras  N Cobo  D Bautista  A L Cuesta-Muñoz  E Fuentes  P Juan-Pico  M J Castro  G Milman  R Mechoulam  A Nadal  F Rodríguez de Fonseca
Institution:(1) Fundación IMABIS, Hospital Carlos Haya, Avenida Carlos Haya 82, 7a Planta, Pabellón A, 29010 Málaga, Spain;(2) Servicio de Anatomía Patológica, Hospital Carlos Haya, Málaga, Spain;(3) Instituto de Bioingeniería, Universidad Miguel Hernández, Elche, Spain;(4) Servicio de Cirugía General y Digestiva, Hospital Carlos Haya, Málaga, Spain;(5) Department of Medicinal Chemistry and Natural Products, Ein Kerem Campus, Hebrew University, Jerusalem, Israel
Abstract:Aims/hypothesis We examined the presence of functional cannabinoid receptors 1 and 2 (CB1, CB2) in isolated human islets, phenotyped the cells producing cannabinoid receptors and analysed the actions of selective cannabinoid receptor agonists on insulin, glucagon and somatostatin secretion in vitro. We also described the localisation on islet cells of: (1) the endocannabinoid-producing enzymes N-acyl-phosphatidyl ethanolamine-hydrolysing phospholipase D and diacylglycerol lipase; and (2) the endocannabinoid-degrading enzymes fatty acid amidohydrolase and monoacyl glycerol lipase. Methods Real-time PCR, western blotting and immunocytochemistry were used to analyse the presence of endocannabinoid-related proteins and genes. Static secretion experiments were used to examine the effects of activating CB1 or CB2 on insulin, glucagon and somatostatin secretion and to measure changes in 2-arachidonoylglycerol (2-AG) levels within islets. Analyses were performed in isolated human islets and in paraffin-embedded sections of human pancreas. Results Human islets of Langerhans expressed CB1 and CB2 (also known as CNR1 and CNR2) mRNA and CB1 and CB2 proteins, and also the machinery involved in synthesis and degradation of 2-AG (the most abundant endocannabinoid, levels of which were modulated by glucose). Immunofluorescence revealed that CB1 was densely located in glucagon-secreting alpha cells and less so in insulin-secreting beta cells. CB2 was densely present in somatostatin-secreting delta cells, but absent in alpha and beta cells. In vitro experiments revealed that CB1 stimulation enhanced insulin and glucagon secretion, while CB2 agonism lowered glucose-dependent insulin secretion, showing these cannabinoid receptors to be functional. Conclusions/interpretation Together, these results suggest a role for endogenous endocannabinoid signalling in regulation of endocrine secretion in the human pancreas. Electronic supplementary material The online version of this article (doi:) contains supplementary material, which is available to authorised users.
Keywords:Anandamide  2-Arachidonoylglycerol  Beta cell  Cannabinoid receptors  Fatty acid amidohydrolase  Glucagon  Human  Insulin  Islets of Langerhans  Somatostatin
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号